# TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention

> **NCT01613482** · PHASE3 · TERMINATED · sponsor: **Centre Oscar Lambret** · enrollment: 13 (actual)

## Conditions studied

- Breast Cancer
- Metastasis
- Sur-expressing Her2-neu

## Interventions

- **RADIATION:** cerebral prophylactic radiation
- **DRUG:** Trastuzumab
- **DRUG:** Other chemotherapy in association with Trastuzumab

## Key facts

- **NCT ID:** NCT01613482
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-08
- **Final completion:** 2012-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613482, "TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT01613482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*